Clinuvel Pharmaceuticals Stock Performance

CLVLF Stock  USD 8.45  0.00  0.00%   
On a scale of 0 to 100, Clinuvel Pharmaceuticals holds a performance score of 10. The firm shows a Beta (market volatility) of -0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Clinuvel Pharmaceuticals are expected to decrease at a much lower rate. During the bear market, Clinuvel Pharmaceuticals is likely to outperform the market. Please check Clinuvel Pharmaceuticals' coefficient of variation, jensen alpha, as well as the relationship between the Jensen Alpha and kurtosis , to make a quick decision on whether Clinuvel Pharmaceuticals' price patterns will revert.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Clinuvel Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile essential indicators, Clinuvel Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Begin Period Cash Flow82.7 M
Total Cashflows From Investing Activities-434.4 K
Free Cash Flow39.4 M
  

Clinuvel Pharmaceuticals Relative Risk vs. Return Landscape

If you would invest  756.00  in Clinuvel Pharmaceuticals on November 13, 2025 and sell it today you would earn a total of  89.00  from holding Clinuvel Pharmaceuticals or generate 11.77% return on investment over 90 days. Clinuvel Pharmaceuticals is currently producing 0.1969% returns and takes up 1.5362% volatility of returns over 90 trading days. Put another way, 13% of traded pink sheets are less volatile than Clinuvel, and 97% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon Clinuvel Pharmaceuticals is expected to generate 1.98 times more return on investment than the market. However, the company is 1.98 times more volatile than its market benchmark. It trades about 0.13 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.12 per unit of risk.

Clinuvel Pharmaceuticals Target Price Odds to finish over Current Price

The tendency of Clinuvel Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 8.45 90 days 8.45 
under 4
Based on a normal probability distribution, the odds of Clinuvel Pharmaceuticals to move above the current price in 90 days from now is under 4 (This Clinuvel Pharmaceuticals probability density function shows the probability of Clinuvel Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon Clinuvel Pharmaceuticals has a beta of -0.47 suggesting as returns on the benchmark increase, returns on holding Clinuvel Pharmaceuticals are expected to decrease at a much lower rate. During a bear market, however, Clinuvel Pharmaceuticals is likely to outperform the market. Additionally Clinuvel Pharmaceuticals has an alpha of 0.3529, implying that it can generate a 0.35 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Clinuvel Pharmaceuticals Price Density   
       Price  

Predictive Modules for Clinuvel Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Clinuvel Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
6.918.459.99
Details
Intrinsic
Valuation
LowRealHigh
8.159.6911.23
Details

Clinuvel Pharmaceuticals Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Clinuvel Pharmaceuticals is not an exception. The market had few large corrections towards the Clinuvel Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Clinuvel Pharmaceuticals, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Clinuvel Pharmaceuticals within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.35
β
Beta against Dow Jones-0.47
σ
Overall volatility
0.35
Ir
Information ratio 0.12

Clinuvel Pharmaceuticals Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Clinuvel Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Clinuvel Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
About 21.0% of the company shares are held by company insiders

Clinuvel Pharmaceuticals Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Clinuvel Pink Sheet often depends not only on the future outlook of the current and potential Clinuvel Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Clinuvel Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding49.4 M
Dividends Paid1.2 M
Forward Annual Dividend Rate0.03
Shares Float37.1 M

Clinuvel Pharmaceuticals Fundamentals Growth

Clinuvel Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Clinuvel Pharmaceuticals, and Clinuvel Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Clinuvel Pink Sheet performance.

About Clinuvel Pharmaceuticals Performance

By analyzing Clinuvel Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Clinuvel Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Clinuvel Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Clinuvel Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. The company was founded in 1987 and is headquartered in Melbourne, Australia. Clinuvel Pharm operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Things to note about Clinuvel Pharmaceuticals performance evaluation

Checking the ongoing alerts about Clinuvel Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Clinuvel Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
About 21.0% of the company shares are held by company insiders
Evaluating Clinuvel Pharmaceuticals' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Clinuvel Pharmaceuticals' pink sheet performance include:
  • Analyzing Clinuvel Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Clinuvel Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
  • Examining Clinuvel Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Clinuvel Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Clinuvel Pharmaceuticals' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Clinuvel Pharmaceuticals' pink sheet. These opinions can provide insight into Clinuvel Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Clinuvel Pharmaceuticals' pink sheet performance is not an exact science, and many factors can impact Clinuvel Pharmaceuticals' pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Clinuvel Pink Sheet analysis

When running Clinuvel Pharmaceuticals' price analysis, check to measure Clinuvel Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clinuvel Pharmaceuticals is operating at the current time. Most of Clinuvel Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Clinuvel Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clinuvel Pharmaceuticals' price. Additionally, you may evaluate how the addition of Clinuvel Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules